CY1116590T1 - Υλικα πολυ οξο-υδροξυ μεταλλικου ιοντος τροποποιημενα με εκλεκτικο συνδετη, χρησεις αυτων και μεθοδοι παρασκευης αυτων - Google Patents

Υλικα πολυ οξο-υδροξυ μεταλλικου ιοντος τροποποιημενα με εκλεκτικο συνδετη, χρησεις αυτων και μεθοδοι παρασκευης αυτων

Info

Publication number
CY1116590T1
CY1116590T1 CY20151100694T CY151100694T CY1116590T1 CY 1116590 T1 CY1116590 T1 CY 1116590T1 CY 20151100694 T CY20151100694 T CY 20151100694T CY 151100694 T CY151100694 T CY 151100694T CY 1116590 T1 CY1116590 T1 CY 1116590T1
Authority
CY
Cyprus
Prior art keywords
methods
oxo
producing
metal ion
electric connector
Prior art date
Application number
CY20151100694T
Other languages
Greek (el)
English (en)
Inventor
Jonathan Joseph Powell
Sylvaine Francoise Aline Bruggraber
Nuno Jorge Rodrigues Faria
Dora Isabel Amaral Pereira
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0702270.0A external-priority patent/GB0702270D0/en
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of CY1116590T1 publication Critical patent/CY1116590T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/295Iron group metal compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02Iron compounds
    • C07F15/025Iron compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/76Metal complexes of amino carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F11/00Compounds containing elements of Groups 6 or 16 of the Periodic Table
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02Iron compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07GCOMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G99/00Subject matter not provided for in other groups of this subclass

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Catalysts (AREA)
CY20151100694T 2007-02-06 2015-08-10 Υλικα πολυ οξο-υδροξυ μεταλλικου ιοντος τροποποιημενα με εκλεκτικο συνδετη, χρησεις αυτων και μεθοδοι παρασκευης αυτων CY1116590T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88838607P 2007-02-06 2007-02-06
GBGB0702270.0A GB0702270D0 (en) 2007-02-06 2007-02-06 Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
EP08709331.6A EP2125847B1 (en) 2007-02-06 2008-02-06 Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation

Publications (1)

Publication Number Publication Date
CY1116590T1 true CY1116590T1 (el) 2017-03-15

Family

ID=39204358

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100694T CY1116590T1 (el) 2007-02-06 2015-08-10 Υλικα πολυ οξο-υδροξυ μεταλλικου ιοντος τροποποιημενα με εκλεκτικο συνδετη, χρησεις αυτων και μεθοδοι παρασκευης αυτων

Country Status (15)

Country Link
US (1) US8058462B2 (https=)
EP (1) EP2125847B1 (https=)
JP (1) JP5756598B2 (https=)
KR (1) KR101514470B1 (https=)
AU (1) AU2008212653B2 (https=)
BR (1) BRPI0807212B1 (https=)
CA (1) CA2676146C (https=)
CY (1) CY1116590T1 (https=)
EA (1) EA019635B1 (https=)
GB (1) GB2451713B (https=)
HR (1) HRP20150944T1 (https=)
IL (1) IL199901A (https=)
MX (1) MX2009008281A (https=)
PL (1) PL2125847T3 (https=)
WO (1) WO2008096130A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20150944T1 (hr) 2007-02-06 2015-10-09 Medical Research Council Materijali poli-okso-hidroksi-metalnih iona modificirani ligandima, njihove uporabe i postupci za njihovu proizvodnju
GB0814326D0 (en) * 2008-08-05 2008-09-10 Medical Res Council Phosphate binding materials and their uses
GB201101299D0 (en) * 2011-01-25 2011-03-09 Medical Res Council Oxygen sensors and their uses
GB201507002D0 (en) * 2015-04-24 2015-06-10 Medical Res Council Copper Oxo-hydroxide nanoparticles and their uses as biocidal agents
GB201517893D0 (en) 2015-10-09 2015-11-25 Medical Res Council Methods for producing carboxylate ligand modified ferric iron hydroxide colloids
WO2017167963A1 (en) * 2016-03-31 2017-10-05 Medical Research Council Methods for producing ferric maltol compositions from ligand modified and ligand coated ferric hydroxides
WO2017167970A1 (en) 2016-03-31 2017-10-05 Medical Research Council Methods for producing ferric maltol compositions from ferrous hydroxides
WO2018029247A1 (en) 2016-08-10 2018-02-15 Medical Research Council Compositions comprising nanosilica particles and their use in methods of activating t lymphocytes for therapy
HUE070809T2 (hu) 2017-09-11 2025-07-28 Pharmacosmos Holding As Vaskomplex vegyületek gyógyászati alkalmazásra
GB202005054D0 (en) 2020-04-06 2020-05-20 Nemysis Ltd Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions for Use in the Treatment or Prevention of Iron Deficiency Associated with Liver Diseases
US20230338545A1 (en) * 2020-09-17 2023-10-26 Syracuse University Complexes of magnesium maltol (3-hydroxy-2-methyl-4h-pyran-4-one) for oral supplementation
JP2024529536A (ja) 2021-08-03 2024-08-06 ファーマコスモス ホールディング エー/エス コンパニオンアニマルの鉄欠乏症の治療における皮下使用のための鉄錯体化合物
CA3280511A1 (en) 2024-07-18 2026-03-01 Malian Biologicals Gmbh Iron supplementation in affective disorders and/or post-traumatic stress disorder (ptsd) and/or serotonin-dependent diseases and iron supplementation in neurodevelopmental or psychiatric disorder

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL264270A (https=) *
US2575347A (en) * 1949-07-14 1951-11-20 Interchem Corp Metallo organic compounds
GB959282A (en) * 1959-08-19 1964-05-27 Hardman & Holden Ltd Improvements relating to organic aluminium compounds
US3076798A (en) * 1961-02-23 1963-02-05 Hausmann Lab Ltd Process for preparing a ferric hydroxide polymaltose complex
US3679377A (en) * 1970-02-17 1972-07-25 Union Oil Co Iron complexes containing aquo,sulfate and hydroxyl ligands
US3821192A (en) * 1971-08-18 1974-06-28 Central Pharmacal Co Process for preparing an iron-saccharide complex
US4162986A (en) * 1977-06-20 1979-07-31 Mooney Chemicals, Inc. Oil-soluble high metal content transitional metal organic oxy, hydroxy, complexes
US4137359A (en) * 1977-10-31 1979-01-30 Mooney Chemicals, Inc. Elastomers with improved metal adhesion
DE4239442C2 (de) * 1992-11-24 2001-09-13 Sebo Gmbh Verwendung eines mit polynuklearen Metalloxidhydroxiden modifizierten Adsorptionsmaterials zur selektiven Elimination von anorganischem Phosphat aus proteinhaltigen Flüssigkeiten
US6177581B1 (en) * 1999-10-12 2001-01-23 The Dow Chemical Company Mixed-metal chelates and process for the preparation thereof
US20030049284A1 (en) * 2001-09-05 2003-03-13 Boccio Jose Ruben Method of increasing the solubility of alphahydrocarboxilic salts, and products obtained by the method
EP1434869B1 (en) 2001-10-08 2010-12-15 Purac Biochem N.V. Method for preparing calcium gluconate
DE60312827T2 (de) * 2002-01-24 2007-12-06 William Marsh Rice University, Houston Teilchen aus organischer Säure und FEOOH (Ferroxanen) und von Ferroxanen abgeleitete Keramiken und Keramikmembrane
US7994217B2 (en) 2002-05-02 2011-08-09 Xanodyne Pharmaceuticals, Inc. Prenatal multivitamin/multimineral supplement
GB0211500D0 (en) 2002-05-18 2002-06-26 Vitra Pharmaceuticals Ltd Method of forming iron hydroxypyrone compounds
DE10249552A1 (de) * 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US6706904B1 (en) 2002-12-04 2004-03-16 Albion International, Inc. Dimetalhydroxy malates
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
US7964568B2 (en) 2003-05-30 2011-06-21 Chromaceutical Advanced Technologies, Inc. Synthesis of high molecular weight iron-saccharidic complexes
WO2005094202A2 (en) * 2004-03-16 2005-10-13 Navinta, Llc Iron sucrose complexes and method of manufacture thereof
US7179939B2 (en) * 2004-03-16 2007-02-20 Navinta Llc Sodium ferric gluconate complexes and method of manufacture thereof
ZA200702421B (en) 2004-10-08 2008-09-25 Unilever Plc Iron complex for use in the treatment and/or prevention of nutritional disorders
DE202005014332U1 (de) 2005-09-09 2006-01-19 Institut für Oberflächenmodifizierung e.V. Metallorganisches Nanopulver
HRP20150944T1 (hr) 2007-02-06 2015-10-09 Medical Research Council Materijali poli-okso-hidroksi-metalnih iona modificirani ligandima, njihove uporabe i postupci za njihovu proizvodnju
TWI592159B (zh) 2007-11-16 2017-07-21 威佛(國際)股份有限公司 藥學組成物
GB0814326D0 (en) * 2008-08-05 2008-09-10 Medical Res Council Phosphate binding materials and their uses

Also Published As

Publication number Publication date
IL199901A0 (en) 2010-04-15
PL2125847T3 (pl) 2015-12-31
WO2008096130A1 (en) 2008-08-14
CA2676146A1 (en) 2008-08-14
AU2008212653A1 (en) 2008-08-14
AU2008212653B2 (en) 2012-05-24
EA200970718A1 (ru) 2010-02-26
BRPI0807212B1 (pt) 2022-01-11
IL199901A (en) 2014-11-30
BRPI0807212A2 (pt) 2014-06-17
EA019635B1 (ru) 2014-05-30
US8058462B2 (en) 2011-11-15
JP5756598B2 (ja) 2015-07-29
GB0802214D0 (en) 2008-03-12
KR101514470B1 (ko) 2015-04-22
JP2010520856A (ja) 2010-06-17
EP2125847B1 (en) 2015-06-17
US20080188555A1 (en) 2008-08-07
CA2676146C (en) 2016-08-09
KR20090121281A (ko) 2009-11-25
HK1138598A1 (en) 2010-08-27
GB2451713B (en) 2009-12-16
MX2009008281A (es) 2009-08-25
GB2451713A (en) 2009-02-11
HRP20150944T1 (hr) 2015-10-09
EP2125847A1 (en) 2009-12-02

Similar Documents

Publication Publication Date Title
CY1116590T1 (el) Υλικα πολυ οξο-υδροξυ μεταλλικου ιοντος τροποποιημενα με εκλεκτικο συνδετη, χρησεις αυτων και μεθοδοι παρασκευης αυτων
CY1118472T1 (el) Υποκατεστημενα ακυλανιλιδια και μεθοδοι χρησης αυτων
CY1122676T1 (el) Αντισωματα εναντι της κλαυδινης 18.2 που ειναι χρησιμα στη διαγνωση του καρκινου
CY1119123T1 (el) Δις-αρυλοσυζευγμενες αρυλοτριαζολονες και η χρηση τους
CY1115236T1 (el) Ενωσεις για την προληψη και τη θεραπεια των καρδιαγγειακων παθησεων
CY1116940T1 (el) Φλυκταινες εμπλουτισμενες σε φωσφολιπιδιο που φερουν παραγοντα ιστου εχουσες αιμοστατικες δραστικοτητες και χρησεις αυτων
CY1118600T1 (el) Μεταλλικα νανοσωματιδια, παρασκευη και χρησεις αυτων
CY1120729T1 (el) Πεπτιδια και συνθεσεις για τη θεραπεια τραυματισμου των αρθρωσεων
EP4389889A3 (en) Compositions and methods for editing rna
ATE541597T1 (de) Implantierbare vorrichtung mit sich langsam auflösendem polymer
CY1121742T1 (el) Αντισωματα s100a4 και θεραπευτικες χρησεις αυτων
CY1112469T1 (el) Μια il-2 μουτεϊνη για θεραπεια ή για προφυλαξη απο ενα αυτοανοσο νοσημα
CY1118069T1 (el) Αντισωματα anti-bcma
CY1118714T1 (el) Υψηλης συγγενειας ανθρωπινα αντισωματα κατα του ανθρωπινου ενεργοποιουμενου απο πρωτεαση υποδοχεα-2
ATE547131T1 (de) Verfahren zur herstellung von biomaterialien mit variabler steifheit
CY1109644T1 (el) 2,4-διαμινο-πυριμιδινες ως αναστολεις audora
CY1116828T1 (el) Πεπτιδια για απευαισθητοποιηση απο αλλεργιογονα
CY1119722T1 (el) Δημιουργια και περιγραφη πληρως ανθρωπινων θεραπευτικων αντισωματων λαμβανομενων μεσω hucal gold ειδικων για ανθρωπινό cd38
CY1120123T1 (el) Μονοκλωνικα αντισωματα κατα της gt468 για τη θεραπεια του καρκινου
CY1118129T1 (el) 5-αλκυνυλ-πυριμιδινες
CY1119219T1 (el) Anti-ceacam5 αντισωματα και χρησεις αυτων
CY1118416T1 (el) Υποκατεστημενες 4-φαινυλο-πυριδινες για τη θεραπεια ασθενειων που σχετιζονται με τον νκ-1 υποδοχεα
CY1116072T1 (el) Ανθρωπινα αντισωματα υψηλης συγγενειας εναντιον ανθρωπινου νευρικου αυξητικου παραγοντα
CY1114872T1 (el) Συνθεσεις και μεθοδοι χρησης αντισωματων εναντι της σκληροστεϊνης
CY1122285T1 (el) Ψημενα προϊοντα